Mariia Lupatsii

Mariia Lupatsii

Auto-generated profile, based on publicly available information

Mariia Lupatsii

Institute of Medical Microbiology, University of Lübeck , Lübeck

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2022 in Gut Microbes
Verified
Journal Article
Open access
VBVerena Bossung
Verena Bossung
MLMariia Lupatsii
Mariia Lupatsii
LDLkhagvademberel Dashdorj
Lkhagvademberel Dashdorj
OTOronzo Tassiello
Oronzo Tassiello
SJSinje Jonassen
Sinje Jonassen
CHChristoph Härtel
Christoph Härtel
Animal models imply that the perinatal exposure to antibiotics has a substantial impact on microbiome establishment of the offspring. We aimed to evaluate the effect of timing of antimicrobial prophylaxis for cesarean section before versus after cord clamping on gut microbiome composition of term born infants. We performed an exploratory, single center randomized controlled clinical trial. We included forty pregnant women with elective cesarean section at term. The intervention group received single dose intravenous cefuroxime after cord clamping (n = 19), the control group single dose intravenous cefuroxime 30 minutes before skin incision (n = 21). The primary endpoint was microbiome signature of infants and metabolic prediction in the first days of life as determined in meconium samples by 16S rRNA gene sequencing. Secondary endpoints were microbiome composition at one month and 1 year of life. In meconium samples of the intervention group, the genus Staphylococcus pre-dominated. In the control group, the placental cross-over of cefuroxime was confirmed in cord blood. A higher amino acid and nitrogen metabolism as well as increased abundance of the genera Cutibacterium, Corynebacterium and Streptophyta were noted (indicator families: Cytophagaceae, Lactobacilaceae, Oxalobacteraceae). Predictive models of metabolic function revealed higher 2ʹfucosyllactose utilization in control group samples. In the follow-up visits, a higher abundance of the genus Clostridium was evident in the intervention group. Our exploratory randomized controlled trial suggests that timing of antimicrobial prophylaxis is critical for early microbiome engraftment but not antimicrobial resistance emergence in term born infants.

5 March 2026 in Human Reproduction Open
Verified
Journal Article
Open access
SGSimon Graspeuntner
Simon Graspeuntner
MLMariia Lupatsii
Mariia Lupatsii
NHNoemi Hamala
Noemi Hamala
AMAntonia Masuch
Antonia Masuch
MDMarion Depenbusch
Marion Depenbusch
GGGeorg Griesinger
Georg Griesinger
STUDY QUESTION: Are previously proposed vaginal microbial community state types (CSTs) valid predictors of IVF success, or do alternative microbial signatures provide stronger associations? SUMMARY ANSWER: Previously proposed CSTs as predictors of implantation, clinical pregnancy, and live birth were not confirmed, while an interaction between Ureaplasma parvum and Lactobacillus iners emerged as a strong negative predictor. WHAT IS KNOWN ALREADY: Infertility affects 17% of the global population. Only one-third of treatment cycles of assisted reproductive technologies result in embryo implantation, and even fewer lead to clinical pregnancy or live births. While early findings have spurred the development of microbiome-based tests for success prediction, evidence on supporting their reliability remains inconclusive. STUDY DESIGN, SIZE, DURATION: This prospective, single-centre study aimed to validate existing, and identify better, microbial predictors of infertility treatment outcomes. A cohort of 266 infertile female patients (age 18–45 years) undergoing a frozen-thawed embryo transfer cycle in an anovulatory regimen (i.e. a cycle with transfer of an embryo following a previous oocyte retrieval, fertilization, and freezing of embryos) was recruited for the study within a timeframe from May 2017 to March 2019. PARTICIPANTS/MATERIALS, SETTING, METHODS: The female, infertile patients, aged 18–45 years, were undergoing routine care. Vaginal swabs were taken prior to embryo transfer and subjected to DNA isolation for 16S-based microbiota analysis. Extended demographic and treatment data were recorded. Clinical outcomes were defined as: (i) implantation, confirmed by a positive hCG test, (ii) clinical pregnancy, and (iii) live birth (defined as the birth of a viable infant). Sequencing data were processed in mothur following established pipelines, and microbial composition (taxonomy) as well as microbial diversity (dissimilarity analyses) were determined using the open-source software R. A prediction model for implantation success was built using binary logistic regression based on abundance of putatively predictive microbial taxa. MAIN RESULTS AND THE ROLE OF CHANCE: This study suggests that vaginal microbial CSTs, alpha-diversity, and the ratio of dominant Lactobacillus species do not correlate in statistical terms or in a clinically meaningful manner with implantation and clinical pregnancy (as a surrogate for endometrial receptivity) or with live birth (as a surrogate for ongoing pregnancy viability). However, Ureaplasma parvum and Lactobacillus iners abundances were identified as negative predictors of embryo implantation, clinical pregnancy, and live birth. A subset of women colonized by these taxa experienced drastically reduced embryo implantation and completely failed to achieve clinical pregnancy or give birth to live offspring, suggesting a potential role of these organisms in implantation failure and reproductive outcome, independent of other influencing factors such as age, oestradiol levels, endometrial thickness etc. LARGE SCALE DATA: The raw sequencing data used for this manuscript are publicly available at the European Nucleotide Archive under accession number PRJEB107113. LIMITATIONS, REASONS FOR CAUTION: This study is a single-centre study warranting further validation cohorts. Given the variable nature of the vaginal microbiota, sample sizes need to be enlarged for better refinement of the analyses. Further, the underlying mechanistical basis of our findings is yet elusive and clinical translation has yet to be established. WIDER IMPLICATIONS OF THE FINDINGS: While this novel association warrants confirmation, the results caution against reliance on previously suggested CSTs as predictors, and highlight the need for refined, reproducible microbiome-based diagnostics in reproductive medicine. STUDY FUNDING/COMPETING INTEREST(S): Financial support was received from the University of Lübeck and the German Center of Infection Research. M.L., A.M., I.P., M.D., and J.R. declare no conflicts of interest. S.G. discloses personal fees from Organon outside the submitted work. T.K.E. discloses honoraria from Ferring; travel support from Ferring, Merck, Theramex, and Gedeon-Richter; and receipt of equipment/materials/laboratory analyses (to institution) from Arthrex, Besins, Merck, and Abbott outside the submitted work. N.H. discloses personal fees from Gedeon Richter, Ferring, and Merck. G.G. reports that his institution received grants or contracts from Besins, Merck, Abbott, Ferring, and Theramex. He has received personal consulting fees, support for travel fees and meeting attendance, and honoraria for lectures or educational events from Organon, Ferring, Merck, Gedeon-Richter, Theramex, Abbott, ReproNovo, Igyxos, OxoLife, Philipps, ReprodWissen, PregLem, Guerbet, Roche, IBSA, and Besins. He also received support for travel and meeting attendance from Merck, Organon, Ferring, Theramex, Gedeon-Richter, and Abbott. Additionally, he holds unpaid leadership positions as a member of the ESHRE Working Group on RIF, the ESHRE Working Group on clinical KPI, and the ESHRE guideline development group on ovarian stimulation. A.S.-M. reports consulting fees and speaker’s fees from Merck, Theramex, and Gedeon-Richter as well as travel support from Merck, Theramex, Gedeon-Richter, IBSA, Ferring, and MSD.

31 January 2020 in Applied Nanoscience
Verified
Journal Article
Open access
PDF file
IFI. Furtat
I. Furtat
MLM. Lupatsii
M. Lupatsii
TMT. Murlanova
T. Murlanova
PVP. Vakuliuk
P. Vakuliuk
AGA. Gaidai
A. Gaidai
AGA. Golub
A. Golub
Antimicrobial resistance of many microbial species can cause to thousands of deaths worldwide, in this regard new therapeutic strategies have to be invented. To address the question, we have prepared nanocomposites on the basis of pyrogenic silicon dioxide with ornidazole immobilized on the surface (ornidasil) and studied their antimicrobial properties and the therapeutic potential. It has also been shown, that in comparison with pure ornidazole the addition of ornidazole to nanocomposite composition can enhance the antimicrobial spectrum, including Gram-positive and Gram-negative bacteria. The most significant bactericidal effect has been reached after more than 24-h treatment with the nanocomposite. Antiadhesive properties of nanocomposite materials were studied using blood types OO+, AO+, BO+, AB+, the degree of bacterial adhesion was estimated using three indexes: average adhesion index, index of erythrocytes involvement, index of microbial adhesion. The effectiveness of the treatment with the nanocomposites obtained was studied on complicated wounds of various etiologies, in particular the wounds caused by diabetic foot syndrome.

23 September 2025 in bioRxiv
Verified
Preprint
Open access
SJShen Jin
Shen Jin
ACAurelie Cenier
Aurelie Cenier
DWDaniela Wetzel
Daniela Wetzel
BABethlehem Arefaine
Bethlehem Arefaine
MMMar Moreno-Gonzalez
Mar Moreno-Gonzalez
MSMelanie Schirmer
Melanie Schirmer
While microbiome perturbations are associated with advanced chronic liver disease (ACLD), microbial disease mechanisms are poorly understood. Using multi-omics analyses of paired saliva and faecal samples from an ACLD cohort, we identified next-to-identical oral and gut bacterial strains (including Veillonella and Streptococcus spp. ) which increased in absolute abundance in the gut of ACLD patients. These translocators uniquely encoded a collagenase-like proteinase ( prtC ) with the potential for gut barrier disruption and prtC faecal abundance was a robust ACLD biomarker (auPR=0.91). CCl 4 -treated mice inoculated with Veillonella and Streptococcus prtC- encoding patient isolates showed exacerbation of gut barrier impairment and hepatic fibrosis. Furthermore, faecal collagenase activity was increased in ACLD patients and experimentally confirmed for the prtC gene from translocating Veillonella parvula . Overall, our study establishes mechanistic links between oral-gut translocation and ACLD pathobiology, and identifies the oral microbiome as an important contributing factor with potential for microbial diagnostics and therapeutics.

30 September 2022 in Geburtshilfe und Frauenheilkunde
Verified
Journal Article
Closed access
NHN Hamala
N Hamala
TETk Eggersmann
Tk Eggersmann
SGSimon Graspeuntner
Simon Graspeuntner
MLM Lupatsii
M Lupatsii
JRJan Rupp
Jan Rupp
GGG Griesinger
G Griesinger
Zielsetzung Die Relevanz des intrauterinen Mikrobioms für die endometriale Rezeptivität und den Verlauf einer Schwangerschaft ist umstritten. Aus methodischer Sicht ist daher besonders relevant, ob eine kontaminationsfreie und atraumatische Probengewinnung aus der Uterushöhle überhaupt möglich ist. Materialien In dieser Pilotstudie erfolgte bei 11 IVF Patientinnen unmittelbar vor dem Embryotransfer ein vaginaler und endometrialer Abstrich. Dabei fungiert ein Führungskatheter in der Zervix als Schutz vor Kontamination eines endometrialen Probengewinnungskatheters. Die vaginale Probe und das Mikrobiom des Führungskatheters (Cervix) gelten als Referenz. Methoden Desoxyribonukleinsäure wurde mittels Qiagen PowerSoil ProKit isoliert. Anschließend erfolgt die Sequenzierung der Amplikons der V3V4-Region des bakteriellen 16S rRNA-Gens (Illumina MiSeq-Sequenzierer, Open-Source-Software mothur, Open-Source-Software R). Ergebnisse Mittels des von uns implementierten Abstrichsystems wurde in allen Proben hinlänglich endometriales Mikrobiom nachgewiesen. Das endometriale Mikrobiom unterschied sich bei 8 von 11 Patientinnen zum vaginalen Mikrobiom, sodass eine Kontamination in 2/11 angenommen werden muss. 10 von 11 Patientinnen wiesen ein Lactobacillus-Spezies dominiertes vaginales Mikrobiom auf. Das endometriale Mikrobiom zeigt sich divers. Die Spitze des Embryotransferkatheters wies eine geringe bis keine Kontamination durch vaginale mikrobielle Spezies auf. 5 von 11 Patientinnen wurden klinisch schwanger. Zusammenfassung Unsere Daten zeigen, dass die mikrobielle Zusammensetzung des Endometriums eine individuelle Diversität aufweist und in vielen Proben durch einen Führungskatheter in der Zervix kontaminationsfrei aus dem Cavum gesammelt werden kann. Die Anwendung des Verfahrens kurz vor Embryotransfer scheint atraumatisch, da es die embryonale Implantation nicht beeinträchtigt. Die dargestellte Methode sollte somit – obgleich des geringen Stichprobenumfanges – eine Rolle bei zukünftiger Betrachtung der Probengewinnung des intrauterinen Mikrobioms darstellen. Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

19 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SGSimon Graspeuntner
Simon Graspeuntner
NKNadja Käding
Nadja Käding
MLMariia Lupatsii
Mariia Lupatsii
RBRonja M. G. Bohm
Ronja M. G. Bohm
EWElisa Wierenberg
Elisa Wierenberg
JRJan Rupp
Jan Rupp
Background: The vaginal microbiome is the first line of defence against sexually transmitted pathogens and plays a key role in human reproduction. One of the most common pathogens colonizing the vagina is Ureaplasma parvum, whose role in vaginal health and the development of reproductive tract diseases is not yet fully understood. We wanted to delineate what significance the presence or acquisition of U. parvum has for the composition, function and stability of the vaginal microbiome.Methods: We sampled cervical swabs from women 18- 22 years of age as part of our longitudinal ESTIMATE study, recorded data on demographics, sexual behaviour and previous sexually transmitted infections (STI), and performed molecular testing of STI twice a year. The vaginal microbiota was analysed using 16S rRNA gene-based analysis in conjunction with predictive modelling of metabolic pathway abundances within the microbiome. A logistic regression model was established that considers the microbial volatility to predict U. parvum acquisition.Findings: We detected U. parvum in 81 of 240 women (33.75%) at baseline visit. Women that tested positive for U. parvum show significantly increased numbers of sexual partners and longer period of being sexually active compared to women without U. parvum colonisation. U. parvum presence is recorded in all CST apart from CST II. In contrast, CST IV-B shows significantly enhanced prevalence of U. parvum (75%) compared to all other CST (up to 36%). U. parvum positivity is accompanied by significantly higher α-diversity and the presence of specific bacterial taxa (mainly Gardnerella spp. and Atopobium spp.). As a functional consequence the microbiome of U. parvum-positive women displays an increased presence of the bifido shunt than U. parvum-negative women, a mechanism which is centrally involved in acetate production. Our longitudinal data assessment shows, that in women with increased number of sexual contacts and longer period of being sexually active, an increase of volatility of Lactobacillus crispatus and L. iners predicts the risk of U. parvum acquisition.Interpretation: The presence of U. parvum is associated with functional changes within the microbiome transferred mainly through Gardnerella spp. and Atopium spp. These taxa presumably transmit an unbalanced acetate vs. lactate availability in the vagina in otherwise asymptomatic and healthy women. Importantly, we centrally highlight the role of volatility of most prevalent vaginal microbes as a predictor to the acquisition of U. parvum, a marker of microbial dysbiosis and a step towards an increased risk of STI acquisition. Our data characterize a previously neglected aspect of microbiome stability in asymptomatic women in more detail, which could also contribute to a better understanding of its impact on the prevention of vaginal diseases.